Despite advances in genetic diagnosis, the management of pancreatic agenesis remains challenging due to the lifelong need for insulin and pancreatic enzyme replacement, as well as the high risk of complications such as recurrent infections, metabolic instability, and developmental delays. Here, INS is linked to Global developmental delay.